T-Cell Transfer Therapy Targeting Mutant KRAS.
作者信息
Rosenberg Steven A, Tran Eric, Robbins Paul F
机构信息
National Cancer Institute, Bethesda, MD
出版信息
N Engl J Med. 2017 Feb 16;376(7):e11.
Abstract
摘要
相似文献
1
T-Cell Transfer Therapy Targeting Mutant KRAS.
N Engl J Med. 2017 Feb 16;376(7):e11.
2
T-Cell Transfer Therapy Targeting Mutant KRAS.
N Engl J Med. 2017 Feb 16;376(7):e11. doi: 10.1056/NEJMc1616637.
3
T-Cell Transfer Therapy Targeting Mutant KRAS.
N Engl J Med. 2017 Feb 16;376(7):e11. doi: 10.1056/NEJMc1616637.
4
Mutant RAS Calms Stressed-Out Cancer Cells.
Dev Cell. 2017 Jan 23;40(2):120-122. doi: 10.1016/j.devcel.2017.01.005.
5
Treatment of KRAS-Mutant Non-Small Cell Lung Cancer: The End of the Beginning for Targeted Therapies.
JAMA. 2017 May 9;317(18):1835-1837. doi: 10.1001/jama.2017.3436.
6
The genetics and biology of KRAS in lung cancer.
Chin J Cancer. 2013 Feb;32(2):63-70. doi: 10.5732/cjc.012.10098. Epub 2012 Jul 2.
7
KRAS and BRAF mutation status in patients with sporadic colorectal cancer: data from two different Mediterranean countries.
Int J Biol Markers. 2011 Oct-Dec;26(4):276-7. doi: 10.5301/JBM.2011.8874.
8
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Oncogene. 2013 Aug 22;32(34):4034-42. doi: 10.1038/onc.2012.402. Epub 2012 Sep 10.
9
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells.
Cell Death Dis. 2013 Sep 26;4(9):e814. doi: 10.1038/cddis.2013.312.
10
KRAS oncogene rearrangements and gene fusions: unexpected rare encounters in late-stage prostate cancers.
Cancer Discov. 2011 Jun;1(1):12-3. doi: 10.1158/2159-8274.CD-11-0045. Epub 2011 Jun 1.
引用本文的文献
1
Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy.
Cancer Sci. 2024 Apr;115(4):1048-1059. doi: 10.1111/cas.16118. Epub 2024 Feb 21.
2
Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives.
World J Gastrointest Oncol. 2023 Jun 15;15(6):911-924. doi: 10.4251/wjgo.v15.i6.911.
3
Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions.
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002647.
4
Deregulation of HLA-I in cancer and its central importance for immunotherapy.
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-002899.
5
POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.
Front Immunol. 2020 Oct 7;11:02193. doi: 10.3389/fimmu.2020.02193. eCollection 2020.
6
Identification and Clinical Application of Immunological Receptors Targeting Mutated Antigens Expressed by Solid Tumors.
Cancers (Basel). 2020 Sep 30;12(10):2818. doi: 10.3390/cancers12102818.
7
Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review.
Cancers (Basel). 2020 May 29;12(6):1398. doi: 10.3390/cancers12061398.
8
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.
Int J Mol Sci. 2019 Sep 18;20(18):4624. doi: 10.3390/ijms20184624.
9
Current Status of Immunotherapies for Treating Pancreatic Cancer.
Curr Oncol Rep. 2019 May 17;21(7):60. doi: 10.1007/s11912-019-0811-5.
10
Kras and Tumor Immunity: Friend or Foe?
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):a031849. doi: 10.1101/cshperspect.a031849.
本文引用的文献
1
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer.
Clin Cancer Res. 2017 Jun 15;23(12):3129-3138. doi: 10.1158/1078-0432.CCR-16-2128. Epub 2016 Dec 22.
2
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.
N Engl J Med. 2016 Dec 8;375(23):2255-2262. doi: 10.1056/NEJMoa1609279.
3
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.
Nat Biotechnol. 2015 Nov;33(11):1152-8. doi: 10.1038/nbt.3344.
4
Molecular and genetic properties of tumors associated with local immune cytolytic activity.
Cell. 2015 Jan 15;160(1-2):48-61. doi: 10.1016/j.cell.2014.12.033.
5
OptiType: precision HLA typing from next-generation sequencing data.
Bioinformatics. 2014 Dec 1;30(23):3310-6. doi: 10.1093/bioinformatics/btu548. Epub 2014 Aug 20.
Zotero 插件